Latest news
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:11:00 GMTAclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:15:00 GMTAclarion's Tool for Finding Back-Pain Sources Reaches Indiana - Stock TitanStock Titan · Tue, 04 Aug 2026 11:00:00 GMTAclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:00:00 GMTAclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 - Orthopedics This WeekOrthopedics This Week · Thu, 30 Jul 2026 17:04:42 GMT